TCL Archive NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection. March 26, 2004
TCL Archive NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification April 10, 1981
TCL Archive FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court. January 15, 2010
TCL Archive “The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.” July 7, 1995
